Journal of Controlled Release 2022
5 papers
The Journal of Controlled Release in 2022 emphasized the development of delivery systems for oncology and regenerative medicine. Research themes centered on modulating the tumor microenvironment, with studies exploring liposomal blockade of adrenergic nerves and biomimetic nanotherapeutics designed to reshape hypoxia and silence CD73. Immunotherapy was a prominent focus, particularly through the intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles. These works highlight a trend toward using bioinspired nanovehicles to improve the distribution and efficacy of combined chemo-radiotherapy.
In addition to cancer-related research, the year’s publications included advancements in tissue engineering, such as the use of dual-function peptides for bone fracture repair. Prolific authors contributing to these developments included Defang Ouyang, Hongzhuo Liu, and Zhonggui He. Collectively, the research from 2022 illustrates a shift toward multifunctional platforms capable of addressing complex physiological barriers. These studies reflect a broader integration of genetic material delivery and targeted nanomedicine within the field of controlled release.
Top Authors
| Author | Papers |
|---|---|
| Christopher Li Hsian Chen | 1 |